These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2180502

  • 21. Evaluation of non-invasive diagnostic tests in detecting cancer of the pancreas.
    Wang JY, Chen FZ, Yang YZ.
    Chin Med J (Engl); 1990 Oct; 103(10):817-20. PubMed ID: 2125254
    [Abstract] [Full Text] [Related]

  • 22. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
    Schmiegel WH, Eberl W, Kreiker C, Kalthoff H, Bützow GH, Jessen K, Klapdor R, Soehendra N, Wargenau M, Classen M.
    Hepatogastroenterology; 1985 Jun; 32(3):141-5. PubMed ID: 2410346
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M.
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C, Sperti C, D'Andrea AA, Costantino V, Filipponi C, Pedrazzoli S.
    Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
    [Abstract] [Full Text] [Related]

  • 27. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM, Aalders JG, Fleuren GJ, Krans M, De Bruijn HW.
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [Abstract] [Full Text] [Related]

  • 28. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
    Gebauer G, Müller-Ruchholtz W.
    Anticancer Res; 1997 Apr; 17(4A):2731-4. PubMed ID: 9252706
    [Abstract] [Full Text] [Related]

  • 29. [CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon].
    Klapdor R, Klapdor U, Bahlo M, Dallek M, Kremer B, van Ackeren H, Schreiber HW, Greten H.
    Dtsch Med Wochenschr; 1984 Dec 21; 109(51-52):1949-54. PubMed ID: 6595110
    [Abstract] [Full Text] [Related]

  • 30. [The value of tumor markers in colorectal cancer].
    Peters KM, Grundmann R.
    Leber Magen Darm; 1989 Jan 21; 19(1):18-25. PubMed ID: 2927234
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Value of serum CA 19-9 determination in the diagnosis of pancreatic carcinoma].
    Pei DP.
    Zhonghua Wai Ke Za Zhi; 1990 Oct 21; 28(10):625-7, 638-9. PubMed ID: 2086060
    [Abstract] [Full Text] [Related]

  • 35. Serum CA19-9 determination in the management of pancreatic cancer.
    van den Bosch RP, van Eijck CH, Mulder PG, Jeekel J.
    Hepatogastroenterology; 1996 Oct 21; 43(9):710-3. PubMed ID: 8799418
    [Abstract] [Full Text] [Related]

  • 36. Increased levels of both carbohydrate antigen 19-9 and duke pancreatic monoclonal antigen type 2 reflect postoperative prognosis in patients with pancreatic carcinoma.
    Shibata K, Iwaki K, Kai S, Ohta M, Kitano S.
    Pancreas; 2009 Aug 21; 38(6):619-24. PubMed ID: 19436235
    [Abstract] [Full Text] [Related]

  • 37. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
    Brockmann J, Emparan C, Hernandez CA, Sulkowski U, Dietl KH, Menzel J, Wolters H, Glodny B, Senninger N.
    Anticancer Res; 2000 Aug 21; 20(6D):4941-7. PubMed ID: 11326643
    [Abstract] [Full Text] [Related]

  • 38. [Prognostically relevant factors in ductal pancreatic cancer].
    Böttger T, Zech J, Weber W, Sorger K, Junginger T.
    Chirurg; 1989 Aug 21; 60(8):521-8. PubMed ID: 2551604
    [Abstract] [Full Text] [Related]

  • 39. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H, Schieder K, Neunteufel W, Bieglmayer C.
    Neoplasma; 1989 Aug 21; 36(4):473-8. PubMed ID: 2770933
    [Abstract] [Full Text] [Related]

  • 40. [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas].
    Yamaguchi K, Nagano M, Torada N, Hamasaki N, Kawakita M, Tanaka M.
    Rinsho Byori; 2004 Apr 21; 52(4):336-9. PubMed ID: 15164602
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.